
    
      Approximately 450 obese and 450 diabetic patients will be enrolled from Lanxi in China. They
      will be randomly assigned into one of the following three groups: Omega-3 fatty acids
      capsules (1 g/d); or omega-3 fatty acids capsules (3 g/d); or placebo capsules. Blood, feces
      and urine samples will be collected before and after treatment. Glucose and lipid parameters
      will be measured.
    
  